Apollo Health Ventures
Apollo is a transatlantic venture capital firm specialised in developing and investing in data-driven biotechnology and health tech ventures.
We invest in game-changing companies at the seed or early stage and build transformative healthcare companies targeting age-related diseases and aging itself. We believe that we can generate significant value by actively cofounding ventures which is a core pillar next to investing in best-in-class companies from our outside dealflow.
We do this by partnering with and enabling leading scientists, research institutes, as well as universities to build and invest in transformative healthcare companies. We identify leading companies at an early stage – based on breakthrough science and led by inspiring teams. We typically invest in companies in preclinical and early clinical stages, mostly participating in Seed through SeriesB financing rounds, ideally as lead or co-lead.
Our team consists of serial entrepreneurs, seasoned biotech investors and scientists across Europe and the US – all with remarkable track records and extensive networks. We actively support our portfolio companies by providing valuable guidance on R&D plans, indication selection strategies, as well extensive operational support where needed. Importantly, we also commit significant resources to recruit key talent for our portfolio companies and to raise follow-on funding.